- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Positive/HER2 negative (HR /HER2-) breast cancer
Total 98885 results
-
Spanish Breast Cancer Research GroupGlaxoSmithKlineCompleted
-
Duke UniversityNational Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Ovarian CancerUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.RecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerItaly
-
Imperial College LondonMedical Research Council; ECMCRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-expressing Advanced Solid TumorsChina
-
Ruijin HospitalRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterNovartisCompleted
-
Spanish Breast Cancer Research GroupPierre Fabre Laboratories; Puma Biotechnology, Inc.RecruitingHER2 Positive Breast Cancer | Hormone Receptor Positive | Early-stage Breast CancerSpain
-
Fudan UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
University of Alabama at BirminghamTesaro, Inc.; Susan G. Komen Breast Cancer Foundation; Translational Breast Cancer... and other collaboratorsRecruitingMetastatic Breast Cancer | HER2 Positive Breast CarcinomaUnited States
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de MedicinaTerminatedLocally Advanced HER2-positive Breast CancerBrazil
-
Second Affiliated Hospital, School of Medicine,...RecruitingColorectal CancerChina
-
Spanish Breast Cancer Research GroupEli Lilly and CompanyActive, not recruiting
-
Centre Leon BerardAmgenRecruitingHER2-positive Breast Cancer | Operable Breast CancerFrance
-
Bolt Biotherapeutics, Inc.Hoffmann-La RocheActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerSpain, United States, Italy
-
National Cancer Center, KoreaActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
Jinming YuJiangsu HengRui Medicine Co., Ltd.UnknownMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
Mayo ClinicRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
Sun Yat-sen UniversityUnknown
-
Asan Medical CenterEisai Inc.; Dong-A ST Co., Ltd.; Samyang Biopharmaceuticals CorporationCompletedMetastatic Breast CancerKorea, Republic of
-
Ottawa Hospital Research InstituteCompleted
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Peking UniversityNot yet recruitingHER2 Positive Gastric CancerChina
-
Cancer Trials IrelandCompletedHER2 Positive Breast CancerIreland
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Ductal Breast Carcinoma in Situ | Lobular Breast Carcinoma in SituUnited States, Canada
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast AdenocarcinomaUnited States
-
Fudan UniversityRecruitingLung Cancer, Non-small CellChina
-
Ruijin HospitalRecruiting
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedBreast Cancer | Breast Cancer - Female | Breast Cancer - MaleUnited States
-
SCRI Development Innovations, LLCSanofi; GlaxoSmithKline; NovartisTerminatedMetastatic Breast Cancer With Intracranial MetastasesUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast Cancer | Carcinoma of the BreastUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerGermany
-
National Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7 | ERBB2 Gene AmplificationUnited States
-
Yale UniversityGenentech, Inc.WithdrawnPaget's Disease of the VulvaUnited States
-
Dana-Farber Cancer InstituteGateway for Cancer Research; Susan G. Komen Breast Cancer FoundationActive, not recruiting
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Belgium, Peru, Italy, Argentina, France
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
University of Michigan Rogel Cancer CenterRecruiting
-
Korean South West Oncology GroupWithdrawnGastric CancerKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Palleos Healthcare GmbHPfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...Terminated
-
Chongqing University Cancer HospitalNot yet recruitingCervical Cancer | Ovarian Cancer | Endometrial Cancer | HER2 Expression